In the present study, we further addressed the high expression of PKM2 in prostate cancer, contributing to COX-2-mediated epithelial–mesenchymal transition (EMT) and tumor metastasis by ERK1/2 signaling in vivo and in vitro. Here, MAPK3 is linked to prostate carcinoma.